Pregnancy should be a privileged opportunity to detect the two gynecologic cancers which occur most frequently during this period (breast cancer excepted). Their detection during pregnancy doesn't influence the maternel prognosis on condition that an ideal therapeutic protocol is applied. The embryonic and foetal toxicity of anticancerous treatments is known to justify medical pregnancy interruption in some cases, and in others, allow their utilization looking forward to foetal viability.